MARKET

SRGA

SRGA

Surgalign Holdings Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.400
+0.160
+4.94%
Opening 13:40 07/05 EDT
OPEN
3.210
PREV CLOSE
3.240
HIGH
3.410
LOW
3.170
VOLUME
25.55K
TURNOVER
53.95K
52 WEEK HIGH
48.60
52 WEEK LOW
2.950
MARKET CAP
22.52M
P/E (TTM)
-0.2311
1D
5D
1M
3M
1Y
5Y
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
DEERFIELD, Ill., June 03, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it has granted restri...
GlobeNewswire · 06/03 13:00
Stocks That Hit 52-Week Lows On Monday
  On Monday, 198 companies reached new 52-week lows.
Benzinga · 05/16 17:59
Here's Why Surgalign Holdings Shares Are Falling Today
Surgalign Holdings Inc (NASDAQ: SRGA) shares are trading lower by 19.73% at $0.15 after the company announced a 1-for-30 reverse stock split. The 1-for-30 reverse stock split will take effect at the opening of trading on the Nasdaq Global Select Market on ...
Benzinga · 05/16 15:53
Surgalign plunges on 1-for-30 reverse stock split
Surgalign (NASDAQ:SRGA) board and stockholders approved a reverse stock split of issued and outstanding shares of its common stock and also authorized the board to select the ratio of the reverse
Seekingalpha · 05/16 14:11
Surgalign Holdings, Inc. Announces 1-for-30 Reverse Stock Split
DEERFIELD, Ill., May 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that at its Annual Meeting ...
GlobeNewswire · 05/16 13:00
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Benzinga · 05/16 12:16
Surgalign Holdings Approves 1-for-30 Reverse Split of Common Stock
MT Newswires · 05/16 11:13
Recap: Surgalign Holdings Q1 Earnings
Surgalign Holdings (NASDAQ:SRGA) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Benzinga · 05/10 22:25
More
No Data
Learn about the latest financial forecast of SRGA. Analyze the recent business situations of Surgalign Holdings Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
50.00%Buy
50.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average SRGA stock price target is 40.00 with a high estimate of 60.00 and a low estimate of 30.00.
High60.00
Average40.00
Low30.00
Current 3.400
EPS
Actual
Estimate
-2.88-2.16-1.44-0.72
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 129
Institutional Holdings: 3.97M
% Owned: 60.00%
Shares Outstanding: 6.62M
TypeInstitutionsShares
Increased
21
73.38K
New
22
465.41K
Decreased
13
99.39K
Sold Out
17
62.85K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.88%
Healthcare Equipment & Supplies
-0.80%
Key Executives
Non-Executive Chairman/Independent Director
Sheryl Conley
President/Chief Executive Officer/Director
Terry Rich
Chief Financial Officer
David Lyle
Executive Vice President
Enrico Sangiorgio
Chief Accounting Officer/Vice President
Chris Thunander
Other
William Durall
Independent Director
Thomas Mceachin
Independent Director
Mark Stolper
Independent Director
Paul Thomas
Independent Director
Nicholas Valeriani
No Data
No Data
About SRGA
Surgalign Holdings, Inc. is a medical technology company. The Company is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. It has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. It also has a biomaterials portfolio of advanced and traditional orthobiologics. The Company offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.

Webull offers kinds of Surgalign Holdings Inc stock information, including NASDAQ:SRGA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRGA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SRGA stock methods without spending real money on the virtual paper trading platform.